AMN Healthcare Services Inc
$ 17.87
-3.35%
10 Apr - close price
- Market Cap 714,754,000 USD
- Current Price $ 17.87
- High / Low $ 18.76 / 17.77
- Stock P/E N/A
- Book Value 16.70
- EPS -2.48
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.01 %
- ROE -0.14 %
- 52 Week High 23.74
- 52 Week Low 14.87
About
AMN Healthcare Services, Inc. provides healthcare personnel solutions and staffing services to hospitals and healthcare facilities in the United States. The company is headquartered in Dallas, Taxas.
Analyst Target Price
$22.21
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-19 | 2025-11-06 | 2025-08-07 | 2025-05-08 | 2025-02-20 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-02-15 | 2023-11-02 | 2023-08-03 | 2023-05-04 |
| Reported EPS | 0.22 | 0.39 | 0.3 | 0.45 | 0.75 | 0.61 | 0.98 | 0.97 | 1.32 | 1.97 | 2.38 | 2.49 |
| Estimated EPS | 0.2674 | 0.2 | 0.19 | 0.21 | 0.49 | 0.57 | 0.76 | 0.96 | 1.25 | 1.64 | 2.14 | 2.36 |
| Surprise | -0.0474 | 0.19 | 0.11 | 0.24 | 0.26 | 0.04 | 0.22 | 0.01 | 0.07 | 0.33 | 0.24 | 0.13 |
| Surprise Percentage | -17.7263% | 95% | 57.8947% | 114.2857% | 53.0612% | 7.0175% | 28.9474% | 1.0417% | 5.6% | 20.122% | 11.215% | 5.5085% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 1.64 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AMN
2026-04-10 11:40:00
BMO Capital has assigned a Buy rating to AMN Healthcare Services (AMN) with a price target of $25.00, following a report released on April 7 by analyst Jeffrey Silber. The company's shares closed at $18.63 the previous day. AMN Healthcare Services has an overall analyst consensus of Moderate Buy and reported a quarterly revenue of $748.23 million with a GAAP net loss of $7.7 million in its latest earnings release.
2026-04-09 11:38:34
AMN Healthcare (NYSE: AMN) has scheduled its first-quarter 2026 earnings conference call for Thursday, May 7, 2026, at 5:00 p.m. ET, following an earnings release at approximately 4:15 p.m. ET. The company's healthcare professionals reached over 13 million patients across more than 2,300 healthcare systems in 2025, including 93% of top systems. Historically, similar announcements have resulted in modest positive stock movements, averaging a 2.83% gain the next day.
2026-04-09 09:40:03
AMN Healthcare Services, Inc. (NYSE: AMN) will hold a conference call on Thursday, May 7, 2026, at 5:00 p.m. Eastern Time, to discuss its first quarter 2026 financial results and second quarter 2026 outlook. An earnings news release is expected after market close at approximately 4:15 p.m. Eastern Time on the same day. A live webcast and replay will be accessible via the company's investor relations website.
2026-04-08 10:22:00
The article analyzes Amn Healthcare Services Inc (NYSE: AMN) using AI models, indicating a near-term weak sentiment that may signal a resumption of long-term weakness. It identifies an exceptional 61.4:1 risk-reward setup targeting a 17.3% gain versus a 0.3% risk, and provides three distinct trading strategies for different risk profiles. These strategies include a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Strategy, along with multi-timeframe signal analysis.
2026-04-06 20:40:43
This article discusses the unusual options activity observed in AMN Healthcare (AMN) stock. The analysis points to a sentiment indicator that suggests a bearish outlook from options traders, despite a slightly positive overall market sentiment for AMN. Options trading volume and open interest specifically for puts and calls are examined to infer potential future price movements.
2026-04-05 20:40:43
AMN Healthcare Services Inc (NYSE:AMN) has received a consensus "Hold" recommendation from nine brokerages, with an average 12-month price target of $22.64. The company reported EPS in line with estimates and revenue above estimates in its last quarter, but faces profitability pressures with a negative net margin and P/E. Institutional investors hold a significant majority of the shares, with several firms increasing their stakes.
